Pilot Study of the Antitumor Efficacy and Tolerability of Orally Administered Rrx-001 in Normal and Tumor-Bearing Mice

Oct 29, 2021

Ning S, Oronsky B, Scicinski J, Carter C, Knox S.
J Cancer Res Therap Oncol 4: 1-6. September 18, 2018.